A PNPLA8 frameshift variant in Australian shepherd dogs with hereditary ataxia
- PMID: 35864734
- PMCID: PMC9545373
- DOI: 10.1111/age.13245
A PNPLA8 frameshift variant in Australian shepherd dogs with hereditary ataxia
Abstract
Hereditary ataxias are common among canine breeds with various molecular etiology. We identified a hereditary ataxia in young-adult Australian Shepherd dogs characterized by uncoordinated movements and spasticity, worsening progressively and leading to inability to walk. Pedigree analysis suggested an autosomal recessive transmission. By whole genome sequencing and variant filtering of an affected dog we identified a PNPLA8:c.1169_1170dupTT variant. This variant, located in PNPLA8 (Patatin Like Phospholipase Domain Containing 8), was predicted to induce a PNPLA8:p.(His391PhefsTer394) frameshift, leading to a premature stop codon in the protein. The truncated protein was predicted to lack the functional patatin catalytic domain of PNPLA8, a calcium-independent phospholipase. PNPLA8 is known to be essential for maintaining mitochondrial energy production through tailoring mitochondrial membrane lipid metabolism and composition. The Australian Shepherd ataxia shares molecular and clinical features with Weaver syndrome in cattle and the mitochondrial-related neurodegeneration associated with PNPLA8 loss-of-function variants in humans. By genotyping a cohort of 85 control Australian Shepherd dogs sampled in France, we found a 4.7% carrier frequency. The PNPLA8:c.[1169_1170dupTT] allele is easily detectable with a genetic test to avoid at-risk matings.
Keywords: Weaver syndrome; canine; cattle; mitochondria; neurodegeneration; patatin domain; phospholipase.
© 2022 The Authors. Animal Genetics published by John Wiley & Sons Ltd on behalf of Stichting International Foundation for Animal Genetics.
Conflict of interest statement
Caroline Dufaure de Citres is an employee of Antagene, a company selling DNA tests for animals.
Figures
 
              
              
              
              
                
                
                References
- 
    - Hara, S. , Yoda, E. , Sasaki, Y. , Nakatani, Y. & Kuwata, H. (2019) Calcium‐independent phospholipase A2γ (iPLA2γ) and its roles in cellular functions and diseases. Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids, 1864, 861–868. - PubMed
 
- 
    - Liu, G.Y. , Moon, S.H. , Jenkins, C.M. , Li, M. , Sims, H.F. , Guan, S. et al. (2017) The phospholipase iPLA2γ is a major mediator releasing oxidized aliphatic chains from cardiolipin, integrating mitochondrial bioenergetics and signaling. Journal of Biological Chemistry, 292, 10672–10684. - PMC - PubMed
 
- 
    - Mancuso, D.J. , Kotzbauer, P. , Wozniak, D.F. , Sims, H.F. , Jenkins, C.M. , Guan, S. , et al. (2009) Genetic ablation of calcium‐independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction. Journal of Biological Chemistry, 284, 35632–35644. - PMC - PubMed
 
 
        